Full Logo - OKYO .jpg
OKYO Pharma Announces OK-101 Successfully Achieved Statistical Significance for Multiple Signs and Symptoms of Dry Eye Disease including Ocular Pain Relief in its First-in-Human Phase 2 Trial of OK-101
22. März 2024 07:00 ET | OKYO Pharma LTD
OKYO Pharma Announces OK-101 Successfully Achieved Statistical Significance for Multiple Signs and Symptoms of Dry Eye Disease including Ocular Pain Relief
GMILogo_Vertical-Gradient.png
Machine Translation Market to hit $1.5bn by 2024: Global Market Insights, Inc.
12. April 2017 06:06 ET | Global Market Insights, Inc
Ocean View, Delaware, April 12, 2017 (GLOBE NEWSWIRE) -- The industry statistics report “Machine Translation Market Size By Technology (SMT, RBMT), By Application (Automotive, Electronics, IT,...